ATE75620T1 - Penetrationsverbesserer fuer die transdermale verabreichung von systemisch wirksamen arzneimitteln. - Google Patents

Penetrationsverbesserer fuer die transdermale verabreichung von systemisch wirksamen arzneimitteln.

Info

Publication number
ATE75620T1
ATE75620T1 AT87116753T AT87116753T ATE75620T1 AT E75620 T1 ATE75620 T1 AT E75620T1 AT 87116753 T AT87116753 T AT 87116753T AT 87116753 T AT87116753 T AT 87116753T AT E75620 T1 ATE75620 T1 AT E75620T1
Authority
AT
Austria
Prior art keywords
sulfur
transdermal delivery
penetration enhancers
represent oxygen
chem
Prior art date
Application number
AT87116753T
Other languages
English (en)
Inventor
Gevork Minaskanian
James V Peck
Original Assignee
Whitby Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitby Research Inc filed Critical Whitby Research Inc
Application granted granted Critical
Publication of ATE75620T1 publication Critical patent/ATE75620T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT87116753T 1986-11-19 1987-11-13 Penetrationsverbesserer fuer die transdermale verabreichung von systemisch wirksamen arzneimitteln. ATE75620T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93270886A 1986-11-19 1986-11-19
EP87116753A EP0268218B1 (de) 1986-11-19 1987-11-13 Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln

Publications (1)

Publication Number Publication Date
ATE75620T1 true ATE75620T1 (de) 1992-05-15

Family

ID=25462769

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87116753T ATE75620T1 (de) 1986-11-19 1987-11-13 Penetrationsverbesserer fuer die transdermale verabreichung von systemisch wirksamen arzneimitteln.

Country Status (8)

Country Link
EP (1) EP0268218B1 (de)
JP (1) JPS63150230A (de)
KR (1) KR880005946A (de)
AT (1) ATE75620T1 (de)
AU (1) AU607951B2 (de)
DE (1) DE3778833D1 (de)
ES (1) ES2038154T3 (de)
GR (1) GR3005138T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1319613C (en) * 1986-10-07 1993-06-29 Gevork Minaskanian Penetration enhancers for transdermal delivery of systemic agents
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
ATE165597T1 (de) * 1992-01-20 1998-05-15 Sanol Arznei Schwarz Gmbh 1-oleoylazacycloheptanon(2) enthaltende arzneimittel zur verstärkung des transports durch biologische membranen
WO1995014759A1 (en) * 1993-11-25 1995-06-01 Warwick International Group Limited Bleaching compositions
US6147102A (en) * 1999-10-26 2000-11-14 Curatek Pharmaceuticals Holding, Inc. Clonidine preparations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL246488A (de) * 1959-12-02
FR2152456B1 (de) * 1971-09-16 1974-10-18 Morelle Jean
SU528848A1 (ru) * 1975-03-12 1977-11-05 Филиал Всесоюзного Научно-Исследовательского Химико-Фармацевтического Института Имени С.Орджоникидзе , -(Дитиооксалил)-бис- бутиролактам, про вл ющий антимикробную активность, и способ его получени
GB1553310A (en) * 1975-06-19 1979-09-26 Nelson Res & Dev Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4743588A (en) * 1984-06-13 1988-05-10 Allergan Pharmaceuticals, Inc. Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents
ES8605233A1 (es) * 1985-12-06 1986-03-16 Lazlo Int Sa Procedimiento de obtencion de imidas derivadas de la 2-oxo- pirrolidina
US4886545A (en) * 1986-01-31 1989-12-12 Nelson Research & Development Company Compositions comprising 1-substituted azacycloalkanes and their uses
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
ZA871586B (en) * 1987-03-05 1987-10-28 Aromac Proprietary Limited Fly-trap

Also Published As

Publication number Publication date
AU8132587A (en) 1988-05-26
EP0268218A2 (de) 1988-05-25
DE3778833D1 (de) 1992-06-11
GR3005138T3 (de) 1993-05-24
EP0268218A3 (en) 1988-09-14
KR880005946A (ko) 1988-07-21
JPS63150230A (ja) 1988-06-22
EP0268218B1 (de) 1992-05-06
AU607951B2 (en) 1991-03-21
ES2038154T3 (es) 1993-07-16

Similar Documents

Publication Publication Date Title
ATE76303T1 (de) Penetrationsverbesserer fuer die transdermale verabreichung von systemisch wirksamen arzneimitteln.
AU568590B2 (en) Penetration enhancers for transdermal drug delivery of systemic agents
EP0164998A3 (de) Mittel und Verfahren zur Erhöhung der transdermalen und transmembranen Penetration topischer und systemischer Wirkstoffe
ATE86870T1 (de) Transdermales verabreichungssystem.
NO862750D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive oksindol-derivater.
DE3751761D1 (de) Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln
DK0699068T3 (da) Reduktion af liposominducerede fysiologiske bivirkninger
DK0513832T3 (da) Anvendelse af dibutyladipat og isopropylmyristat i topiske og transdermale produkter
DK164257C (da) Transdermalt farmaceutisk praeparat
ATE75620T1 (de) Penetrationsverbesserer fuer die transdermale verabreichung von systemisch wirksamen arzneimitteln.
ES2065912T3 (es) Composiciones para mejorar la penetracion cutanea de agentes farmacologicamente activos.
DE59000613D1 (de) Pflaster zur transdermalen anwendung.
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
AU610839B2 (en) Transdermal administration of amines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee